The relationship between thyroiditis and polycystic ovary syndrome: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 10, 2013, Pages 880-889

  Du, Danfeng ^a   Li, Xuelian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Atuoimmune diseases; Meta analysis; Polycystic ovary syndrome; Thyroiditis

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN;

ARTICLE; AUTOIMMUNE THYROIDITIS; DATA BASE; DISEASE ASSOCIATION; GOITER; HORMONE SUBSTITUTION; HUMAN; INFORMATION PROCESSING; OVARY POLYCYSTIC DISEASE; PREVALENCE; SYSTEMATIC REVIEW; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; WOMEN'S HEALTH;

EID: 84887648107     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochen-hauer ES and Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749.
2. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E and Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Poly-cystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010; 95: 2038-2049.
3. Fux Otta C, Fiol de Cuneo M and Szafryk de Mereshian P. [Polycystic ovary syndrome: phys-iopathology review]. Rev Fac Cien Med Univ Nac Cordoba 2013; 70: 27-30.
4. Buccola JM and Reynolds EE. Polycystic ovary syndrome: a review for primary providers. Prim Care 2003; 30: 697-710.
5. Hefer-Frischmuth K, Walch K, Huebl W, Baum-uehlner K, Tempfer C and Hefer L. Serologic markers of autoimmunity in women with poly-cystic ovary syndrome. Fertil Steril 2010; 93: 2291-2294.
6. Gleicher N, Barad D and Weghofer A. Functional autoantibodies, a new paradigm in autoim-munity? Autoimmun Rev 2007; 7: 42-45.
7. Artini PG, Uccelli A, Papini F, Simi G, Di Berardi-no OM, Ruggiero M and Cela V. Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity. Gynecol Endocrinol 2013; 29: 36-41.
8. Cooper DS. Clinical practice. Subclinical hypo-thyroidism. N Engl J Med 2001; 345: 260-265.
9. Dayan CM and Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-107.
10. Garelli S, Masiero S, Plebani M, Chen S, Fur-maniak J, Armanini D and Betterle C. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013; 169: 248-251.
11. Janssen OE, Mehlmauer N, Hahn S, Offner AH and Gartner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-369.
12. Ott J, Aust S, Kurz C, Nouri K, Wirth S, Huber JC and Mayerhofer K. Elevated antithyroid peroxi-dase antibodies indicating Hashimoto's thy-roiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil Steril 2010; 94: 2895-2897.
13. Kachuei M, Jafari F, Kachuei A and Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2012; 285: 853-856.
14. Anaforoglu I, Topbas M and Algun E. Relative associations of polycystic ovarian syndrome vs metabolic syndrome with thyroid function, volume, nodularity and autoimmunity. J Endocri-nol Invest 2011; 34: e259-e264.
15. Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN and Pal SK. Thyroid disorders in poly-cystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab 2013; 17: 304-309.
16. Unuane D, Tournaye H, Velkeniers B and Poppe K. Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab 2011; 25: 861-873.
17. Poppe K, Velkeniers B and Glinoer D. Thyroid disease and female reproduction. Clin Endocri-nol (Oxf) 2007; 66: 309-321.
18. Poppe K, Glinoer D, Tournaye H, Devroey P, Schiettecatte J, Haentjens P and Velkeniers B. Thyroid autoimmunity and female infertility. Verh K Acad Geneeskd Belg 2006; 68: 357-377.
19. Krassas GE, Poppe K and Glinoer D. Thyroid function and human reproductive health. En-docr Rev 2010; 31: 702-755.
20. Muderris II, Boztosun A, Oner G and Bayram F. Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroid-ism. Ann Saudi Med 2011; 31: 145-151.
21. Mutinati M, Desantis S, Rizzo A, Zizza S, Ventri-glia G, Pantaleo M and Sciorsci RL. Localization of thyrotropin receptor and thyroglobulin in the bovine corpus luteum. Anim Reprod Sci 2010; 118: 1-6.
22. Mintziori G, Anagnostis P, Toulis KA and Goulis DG. Thyroid diseases and female reproduction. Minerva Med 2012; 103: 47-62.
23. Mutinati M, Rizzo A and Sciorsci RL. Cystic ovarian follicles and thyroid activity in the dairy cow. Anim Reprod Sci 2013; 138: 150-154.
24. Katulande P, Kariyawasam SS, Senanayake HM and Weerakkodi M. Multicystic ovaries and pituitary pseudo-adenoma associated with primary hypothyroidism. J Obstet Gynaecol 2013; 33: 17-19.
25. Yang JH, Wu MY, Chen MJ, Chen SU, Yang YS and Ho HN. Increased matrix metalloprotein-ase-2 and tissue inhibitor of metalloprotein-ase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis. Fer-til Steril 2009; 91: 2193-2198.
26. Li Q, Yang G, Wang Y, Zhang X, Sang Q, Wang H, Zhao X, Xing Q, He L and Wang L. Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients. Hum Genet 2011; 129: 553-561.
27. Zou S, Sang Q, Wang H, Feng R, Li Q, Zhao X, Xing Q, Jin L, He L and Wang L. Common genetic variation in CYP1B1 is associated with concentrations of T(4), FT(3) and FT(4) in the sera of polycystic ovary syndrome patients. Mol Biol Rep 2013; 40: 3315-3320.
28. Davidson A and Diamond B. Autoimmune diseases. N Engl J Med 2001; 345: 340-350.
29. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med 2002; 11: 585-599.
30. Bannatyne P, Russell P and Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990; 9: 191-207.
31. Suh YL. Autoimmune oophoritis--a case report. J Korean Med Sci 1992; 7: 284-290.
32. Avrameas S and Selmi C. Natural autoantibod-ies in the physiology and pathophysiology of the immune system. J Autoimmun 2013; 41: 46-49.
33. Fenichel P, Gobert B, Carre Y, Barbarino-Mon-nier P and Hieronimus S. Polycystic ovary syndrome in autoimmune disease. Lancet 1999; 353: 2210.
34. Forges T, Monnier-Barbarino P, Faure GC and Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004; 10: 163-175.
35. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236.
36. Canellada A, Alvarez I, Berod L and Gentile T. Estrogen and progesterone regulate the IL-6 signal transduction pathway in antibody secreting cells. J Steroid Biochem Mol Biol 2008; 111: 255-261.
37. Escobar-Morreale HF, Luque-Ramirez M and Gonzalez F. Circulating infammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011; 95: 1048-1058, e1041-e1042.
38. Petrikova J, Lazurova I and Yehuda S. Polycys-tic ovary syndrome and autoimmunity. Eur J Intern Med 2010; 21: 369-371.
39. Ghosh S, Kabir SN, Pakrashi A, Chatterjee S and Chakravarty B. Subclinical hypothyroid-ism: a determinant of polycystic ovary syndrome. Horm Res 1993; 39: 61-66.
40. Sanjeevaiah AR, Sanjay S, Deepak T, Sharada A and Srikanta SS. Precocious puberty and large multicystic ovaries in young girls with primary hypothyroidism. Endocr Pract 2007; 13: 652-655.
41. Dittrich R, Kajaia N, Cupisti S, Hoffmann I, Beckmann MW and Mueller A. Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. Reprod Biomed Online 2009; 19: 319-325.
42. Morteza Taghavi S, Rokni H and Fatemi S. Met-formin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diab Vasc Dis Res 2011; 8: 47-48.
43. Rotondi M, Cappelli C, Magri F, Botta R, Dioni-sio R, Iacobello C, De Cata P, Nappi RE, Castel-lano M and Chiovato L. Thyroidal effect of met-formin treatment in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2011; 75: 378-381.
44. Mueller A, Schof C, Dittrich R, Cupisti S, Oppelt PG, Schild RL, Beckmann MW and Haberle L. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome. Hum Reprod 2009; 24: 2924-2930.